Gene therapy and ovarian cancer: a review

Obstet Gynecol. 1997 Jan;89(1):145-55. doi: 10.1016/s0029-7844(96)00296-7.


Objective: To provide the obstetrician-gynecologist with the basic concepts of gene therapy, an overview of cancer gene therapy treatment strategies, and a summary of currently approved human gene therapy protocols for ovarian carcinoma.

Data sources: A computerized search of articles published through December 1995 was performed on the MEDLINE data base. Additional sources were identified through cross-referencing.

Methods of study selection: All identified references were reviewed with particular attention to their relevance to gene therapy for ovarian cancer.

Tabulation, integration, and results: Each reference was reviewed to determine the relevant contribution to the fundamental science of gene therapy. Particular attention was paid to those studies that offered a rational strategy that might contribute to therapy for ovarian malignancy.

Conclusion: Advances in molecular biology, immunology, and virology have enabled the concept of gene therapy for neoplastic disorders to become a reality. Given the lack of effective conventional therapy, those patients with recurrent or refractory ovarian cancer should be considered for currently approved investigational gene therapy protocols.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Clinical Trials as Topic
  • Female
  • Genetic Therapy / methods*
  • Humans
  • Immunotherapy
  • Mutation
  • Ovarian Neoplasms / therapy*


  • Adjuvants, Immunologic